65,437 trials
Cardiac Surgery · Erythrocyte Transfusion
Primary: The Change in the Composite Multiple Organ Dysfunction Score (MODS) From the Pre-operative Baseline. The Worst Post-operative Values of Each Component of MODS Will be…
Tobacco Use Disorder
Primary: 7-day Point Prevalence Smokeless Tobacco Abstinence Biochemically Confirmed With Urine Cotinine at the End of 12 Weeks of Treatment. — 30; 23 participants
Healthy Adults With Subjective Memory Complaints
Primary: Changes From Baseline in Working Memory Domain Z-score — -0.21955; -0.15432; -0.08842; 0.29594 z-score
Head and Neck Cancer
Primary: Time to Progression — 44.2 Months
Gastroparesis
Primary: Symptom Response as Assessed by the Gastroparesis Cardinal Symptom Index. — 6.8; 10.1 units on a scale
Lymphoma, Mantle-Cell
Primary: Correlation Coefficient Between Change From Baseline in Fluoro-L-thymidine Positron Emission Tomography (FLT-PET) Maximum Standard Uptake Value (SUVmax) and in…
Post Caesarean Analgesia
Primary: Duration of Effective Analgesia — 351; 380; 247 minutes
Monoclonal Gammopathy of Undetermined Significance · Multiple Myeloma · Smoldering Multiple Myeloma
Primary: Changes in M-protein Levels — 1.65; 2.24 g/dL — p=.23
Myopia · Astigmatism · Hyperopia
Primary: Percentage of Subjects With Visibly Clean Lenses — 44.5; 39.8; 35.0; 31.3 percentage of subjects
Localized Aggressive Periodontitis
Primary: Assessment of Change in Clinical Attachment Level (CAL) — -14.07; -37.48 percentage of change
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Change From Baseline in Standardized Forced Expiratory Volume in 1 Second (FEV1) Area Under the Curve (AUC) (0-12 Hours (h)) — 0.211; 0.117; 0.112; -0.021 Liter
Chronic Lymphocytic Leukemia With 17p Deletion · Small Lymphocytic Lymphoma With 17p Deletion
Primary: Overall Response Rate — 77.8 % of participants with response by PI
Hepatitis C · Alcohol Use Disorders
Primary: Number of Drinking Days in the Past Two Weeks — 8.6; 8.9; 6.8; 7.1 Number of Drinking Days/2 weeks — p=<0.01
Interdisciplinary Communication · Management, Medication Therapy
Primary: Incident Rate for Communication Events — 47.6; 34.74; 34.07 mean events per observation — p=0.01
Relapsing-Remitting Multiple Sclerosis · Multiple Sclerosis
Primary: Summary of Treatment-emergent Adverse Events (TEAEs) Occurring Post-BG00012 Dosing (Add-on Therapy Period) — 95; 100; 72; 70 percentage of participants